123 related articles for article (PubMed ID: 20026760)
1. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research.
Liao TD; Yang XP; D'Ambrosio M; Zhang Y; Rhaleb NE; Carretero OA
Hypertension; 2010 Feb; 55(2):459-67. PubMed ID: 20026760
[TBL] [Abstract][Full Text] [Related]
2. Ac-SDKP reverses cardiac fibrosis in rats with renovascular hypertension.
Peng H; Carretero OA; Brigstock DR; Oja-Tebbe N; Rhaleb NE
Hypertension; 2003 Dec; 42(6):1164-70. PubMed ID: 14581293
[TBL] [Abstract][Full Text] [Related]
3. Antifibrotic effect of Ac-SDKP and angiotensin-converting enzyme inhibition in hypertension.
Rasoul S; Carretero OA; Peng H; Cavasin MA; Zhuo J; Sanchez-Mendoza A; Brigstock DR; Rhaleb NE
J Hypertens; 2004 Mar; 22(3):593-603. PubMed ID: 15076166
[TBL] [Abstract][Full Text] [Related]
4. Reduction of cardiac fibrosis decreases systolic performance without affecting diastolic function in hypertensive rats.
Cingolani OH; Yang XP; Liu YH; Villanueva M; Rhaleb NE; Carretero OA
Hypertension; 2004 May; 43(5):1067-73. PubMed ID: 15023934
[TBL] [Abstract][Full Text] [Related]
5. Novel anti-inflammatory mechanisms of N-Acetyl-Ser-Asp-Lys-Pro in hypertension-induced target organ damage.
Sharma U; Rhaleb NE; Pokharel S; Harding P; Rasoul S; Peng H; Carretero OA
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1226-32. PubMed ID: 18178715
[TBL] [Abstract][Full Text] [Related]
6.
Peng H; Xu J; Yang XP; Kassem KM; Rhaleb IA; Peterson E; Rhaleb NE
Can J Physiol Pharmacol; 2019 Aug; 97(8):753-765. PubMed ID: 30998852
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibitors: a new mechanism of action.
Peng H; Carretero OA; Vuljaj N; Liao TD; Motivala A; Peterson EL; Rhaleb NE
Circulation; 2005 Oct; 112(16):2436-45. PubMed ID: 16216963
[TBL] [Abstract][Full Text] [Related]
8. N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo.
Wang D; Carretero OA; Yang XY; Rhaleb NE; Liu YH; Liao TD; Yang XP
Am J Physiol Heart Circ Physiol; 2004 Nov; 287(5):H2099-105. PubMed ID: 15256375
[TBL] [Abstract][Full Text] [Related]
9. Characterization and localization of Ac-SDKP receptor binding sites using 125I-labeled Hpp-Aca-SDKP in rat cardiac fibroblasts.
Zhuo JL; Carretero OA; Peng H; Li XC; Regoli D; Neugebauer W; Rhaleb NE
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H984-93. PubMed ID: 17028162
[TBL] [Abstract][Full Text] [Related]
10. Knockout of ACE-N facilitates improved cardiac function after myocardial infarction.
Suhail H; Peng H; Xu J; Sabbah HN; Matrougui K; Liao TD; Ortiz PA; Bernstein KE; Rhaleb NE
J Mol Cell Cardiol Plus; 2023 Mar; 3():. PubMed ID: 36778784
[TBL] [Abstract][Full Text] [Related]
11. Tβ4-Ac-SDKP pathway: Any relevance for the cardiovascular system?
Kassem KM; Vaid S; Peng H; Sarkar S; Rhaleb NE
Can J Physiol Pharmacol; 2019 Jul; 97(7):589-599. PubMed ID: 30854877
[TBL] [Abstract][Full Text] [Related]
12. Renalase attenuates hypertension, renal injury and cardiac remodelling in rats with subtotal nephrectomy.
Yin J; Lu Z; Wang F; Jiang Z; Lu L; Miao N; Wang N
J Cell Mol Med; 2016 Jun; 20(6):1106-17. PubMed ID: 26923216
[TBL] [Abstract][Full Text] [Related]
13. Chronic kidney disease increases the susceptibility to negative effects of low and high potassium intake.
Gritter M; Wei KY; Wouda RD; Musterd-Bhaggoe UM; Dijkstra KL; Kers J; Ramakers C; Vogt L; de Borst MH; Danser AHJ; Hoorn EJ; Rotmans JI
Nephrol Dial Transplant; 2024 Apr; 39(5):795-807. PubMed ID: 37813819
[TBL] [Abstract][Full Text] [Related]
14. Ac-SDKP attenuates ER stress-stimulated collagen production in cardiac fibroblasts by inhibiting CHOP-mediated NF-κB expression.
Suhail H; Peng H; Matrougui K; Rhaleb NE
Front Pharmacol; 2024; 15():1352222. PubMed ID: 38495093
[TBL] [Abstract][Full Text] [Related]
15. Scientific letter: Ac-SDKP (N-acetyl-seryl-aspartyl-lysyl-proline) and Galectin-3 levels in tuberculous pericardial effusion: implications for pathogenesis and prevention of pericardial constriction.
Ntsekhe M; Matthews K; Wolske J; Badri M; Wilkinson KA; Wilkinson RJ; Sturrock ED; Mayosi BM
Heart; 2012 Sep; 98(17):1326-8. PubMed ID: 22842991
[No Abstract] [Full Text] [Related]
16. Femtosecond laser-patterned nanopore arrays for surface-mediated peptide treatment.
Zachman AL; Hofmeister LH; Costa L; Boire TC; Hwang YS; Hofmeister WH; Sung HJ
Nanomedicine; 2014 Jan; 10(1):11-4. PubMed ID: 24090768
[TBL] [Abstract][Full Text] [Related]
17. Renal and cardiac effects of the PDE9 inhibitor BAY 73-6691 in 5/6 nephrectomized rats.
Chen X; Delić D; Cao Y; Zhang Z; Wu H; Hasan AA; Gaballa MMS; Yin L; Krämer BK; Klein T; Shi X; He B; Shen L; Hocher B
Pflugers Arch; 2024 May; 476(5):755-767. PubMed ID: 38305876
[TBL] [Abstract][Full Text] [Related]
18. Role of the anaphylatoxin receptor C5aR2 in angiotensin II induced hypertension and hypertensive end organ damage.
Dreher L; Bode M; Ehnert N; Meyer-Schwesinger C; Wiech T; Köhl J; Huber TB; Freiwald T; Herrnstadt GR; Wenzel UO
Am J Hypertens; 2024 Jun; ():. PubMed ID: 38934290
[TBL] [Abstract][Full Text] [Related]
19. N-acetyl-seryl-aspartyl-lysyl-proline is a valuable endogenous antifibrotic peptide for kidney fibrosis in diabetes: An update and translational aspects.
Kanasaki K
J Diabetes Investig; 2020 May; 11(3):516-526. PubMed ID: 31997585
[TBL] [Abstract][Full Text] [Related]
20. The Pathophysiological Role of Thymosin β4 in the Kidney Glomerulus.
Mason WJ; Vasilopoulou E
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
